# Afferent Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/afferent-pharmaceuticals

- Industry: Pharmaceuticals
- Headquarters: San Mateo, US
- Website: www.afferentpharma.com
- Total disclosed funding: $78M
- Latest round: Series C (Jul 8, 2015)
- Investors on record: 9

## About

Founded in 2009 and based in San Mateo, California, Afferent Pharmaceuticals is a bio-pharmaceutical company, focused on developing medicines to treat chronic pain by targeting P2X3 receptors in nerve fibers.

## Funding rounds

- Series C, Jul 8, 2015, $55M — New Leaf Venture Partners, Tekla Capital Management, Fidelity Investments, Jennison Associates, Redmile Group, Partner Fund Management
- Series A, Dec 16, 2009, $23M — Domain Associates, Pappas Capital, New Leaf Venture Partners, Third Rock Ventures

## Investors

- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series A
- Pappas Capital (https://capitalatlas.ai/funds/pappas-capital) — Series A
- New Leaf Venture Partners (https://capitalatlas.ai/funds/new-leaf-venture-partners) — Series A, Series C
- Third Rock Ventures (https://capitalatlas.ai/funds/third-rock-ventures) — Series A
- Tekla Capital Management (https://capitalatlas.ai/funds/tekla-capital-management) — Series C
- Fidelity Investments (https://capitalatlas.ai/funds/fidelity-investments) — Series C
- Jennison Associates — Series C
- Redmile Group (https://capitalatlas.ai/funds/redmile-group) — Series C
- Partner Fund Management — Series C